Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature
Office of the Revisor of Statutes

SF 1098

Status in the House for the 91st Legislature (2019 - 2020)

Current bill text: 4th Engrossment
Version List
Companion: HF1246
Companion Text
House Search
Revisor number: 19-3293
Session Law Chapter: 78
Long Description
Further Committee Actions
Fiscal Notes

Description

Prescription Drug Price Transparency Act established, drug manufacturer price information submission to health commissioner required, civil penalties provided report required, and appropriations modified.

Authors (33)

Senate Authors (5)

Actions

House

04/28/2020
Received from Senate
pg. 7287
04/28/2020
Senate file first reading, referred to Ways and Means
pg. 7288
05/05/2020
Committee report, to adopt
pg. 7988
05/05/2020
Second reading
pg. 7996
05/07/2020
House rule 1.21, placed on Calendar for the Day Saturday, May 9, 2020
pg. 8250
05/09/2020
Third reading
pg. 8333
05/09/2020
Bill was passed
pg. 8333 vote: 99-33
Presented to Governor 5/12/2020
Governor approval 05/12/2020
Secretary of State, Filed 05/12/2020
pg. 8669
Chapter number 78

Senate

02/11/2019
Introduction and first reading
pg. 332 Intro
02/11/2019
Referred to Health and Human Services Finance and Policy
03/27/2019
Comm report: To pass as amended and re-refer to Judiciary and Public Safety Finance and Policy
pg. 1380a 1
02/20/2020
Comm report: To pass as amended and re-refer to Finance
pg. 4812a 2
03/11/2020
Comm report: To pass as amended
pg. 5401a 3
03/11/2020
Second reading
pg. 5402
04/20/2020
Special Order: Amended
pg. 5800a 4
04/20/2020
Third reading Passed
pg. 5810 vote: 63-2
05/11/2020
Returned from House
pg. 6447
Presentment date 05/12/2020
05/15/2020
Governor's action Approval 05/12/2020
pg. 7048
05/15/2020
Secretary of State Chapter 78 05/12/2020
pg. 7048
Effective date 07/01/20